Human papillomaviruses and cervical cancer.
Carcinoma of the uterine cervix, a leading cause of cancer death in women worldwide, is initiated by infection with high-risk types of human papillomaviruses (HPVs). This review summarizes laboratory studies over the past 20 years that have elucidated the major features of the HPV life cycle, identified the functions of the viral proteins, and clarified the consequences of HPV infection for their host cells. This information has allowed the development of various strategies to prevent or treat infections, including prophylactic vaccination with virus-like particles, therapeutic vaccination against viral proteins expressed in cancer cells, and antiviral approaches to inhibit virus replication, spread, or pathogenesis. These strategies have the potential to cause a dramatic reduction in the incidence of cervical carcinoma and serve as the prototype for comprehensive efforts to combat virus-induced tumors.
DiMaio
Daniel
D
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Liao
John B
JB
D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000472:pathogenicity* / Q000502:physiology*; D030361:Papillomavirus Infections / Q000503:physiopathology / Q000517:prevention & control / Q000821:virology*; D002583:Uterine Cervical Neoplasms / Q000503:physiopathology / Q000517:prevention & control / Q000821:virology*